Limited Availability of Nirsevimab in the United States—Interim CDC Recommendations to Protect Infants from Respiratory Syncytial Virus (RSV) during the 2023–2024 Respiratory Virus Season

https://emergency.cdc.gov/han/2023/han00499.asp?utm_campaign=morning_rounds&utm_medium=email&_hsmi=279704342&_hsenc=p2ANqtz-9i8EGhHZHAMYy-YCrHPh2D-r64JMdjAhzqagQEwv3DZxgoPY2dxLX1itST9mfR9unAnVZ7VVo5YenEHaydELteH7mivg&utm_content=279704342&utm_source=hs_email